These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan. Akawaza S, Kawasaki E, Yano M, Abiru N, Yamaguchi Y, Nagataki S. Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640 [Abstract] [Full Text] [Related]
3. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Yamaguchi Y, Akazawa S, Nagataki S. J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036 [Abstract] [Full Text] [Related]
6. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Takao Y, Yamaguchi Y, Akazawa S, Nagataki S. Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321 [Abstract] [Full Text] [Related]
8. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM. Roll U, Nuber A, Schröder A, Gerlach E, Janka HU, Ziegler AG. Diabetes Care; 1995 Feb; 18(2):210-5. PubMed ID: 7729299 [Abstract] [Full Text] [Related]
10. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus. Imagawa A, Itoh N, Hanafusa T, Katsura H, Yamaguchi A, Takeda A, Iwahashi H, Nakajima H, Miyagawa J, Namba M, Kuwajima M, Matsuzawa Y. Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827 [Abstract] [Full Text] [Related]
11. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG. Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724 [Abstract] [Full Text] [Related]
14. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, Graus F. Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684 [Abstract] [Full Text] [Related]
15. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A. J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356 [Abstract] [Full Text] [Related]
16. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA. Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004 [Abstract] [Full Text] [Related]
19. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. Seissler J, Amann J, Mauch L, Haubruck H, Wolfahrt S, Bieg S, Richter W, Holl R, Heinze E, Northemann W. J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591 [Abstract] [Full Text] [Related]
20. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome. Richter W, Seissler J, Northemann W, Wolfahrt S, Meinck HM, Scherbaum WA. Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707 [Abstract] [Full Text] [Related] Page: [Next] [New Search]